Popis: |
Idiopathic pulmonary fibrosis (IPF) is a severe progressive fibrotic lung disease. During the past few years two orally administered drug candidates (pirfenidone and nintedanib) for slowing the progression of IPF were approved for clinical practice. Our research group discovered a potential antifibrotic drug, tilorone, using a high throughput screening and … |